EV-treated mice showed reduced levels of steatosis, liver damage (AST, ALT), liver triglycerides, total cholesterol, hepatic expression of TNF-α, IL-1, and IL-6, and restored insulin sensitivity. This evidence concerns the gene IL1B and steatosis.